IndraLab
Statements
USP37 is modified
5
|
1
23
4
sparser
"A mutation in the KEN box degron site affects the stability of USP37 and its ability to deubiquitinate cyclin A. The APC-CDH1 complex does not recognize USP37 as a substrate during S/G2, possibly due to phosphorylation of USP37 by cyclin-dependent kinase 2 (CDK2)/cyclin A. Deubiquitination and phosphorylation of CDH1 by CDKs dissociates CDH1 from the core APC complex during S/G2."
| PMC
USP37 affects Snail1
|
22
USP37 affects cell population proliferation
|
2
13
USP37 activates cell population proliferation.
|
1
9
USP37 activates cell population proliferation. 8 / 8
|
1
7
USP37 bound to HA-14-3-3gamma activates cell population proliferation. 1 / 1
|
1
USP37-C350S activates cell population proliferation. 1 / 1
|
1
USP37 inhibits cell population proliferation.
|
1
4
USP37 inhibits cell population proliferation. 5 / 7
|
1
4
reach
"Since concomitant loss of REST and USP37 expression attenuated p27 stabilization and differentiation and rescued cell proliferation, our data strongly suggest that repression of USP37 and consequent p27 degradation, are important for REST dependent maintenance of cell proliferation."
|
7
9
USP37 activates epithelial to mesenchymal transition.
|
7
8
USP37 inhibits epithelial to mesenchymal transition.
|
1
USP37 inhibits epithelial to mesenchymal transition. 1 / 1
|
1
USP37 affects Neoplasm Invasiveness
|
3
12
USP37 activates Neoplasm Invasiveness.
|
3
10
USP37 inhibits Neoplasm Invasiveness.
|
2
reach
"Many recent studies have highlighted the significant role of E3 ubiquitin ligases, deubiquitinases or substrate translocation between cell compartments, leading to substrate stability motivated us to explore the effect of HBx driven exodus of USP37 from the nucleus vis-a-vis its intracellular stability."
sparser
"In medulloblastomas, REST expression could decrease cyclin-dependent kinase (CDK)NIB/p27 (a CDK inhibitor) by repressing ubiquitin specific peptidase 37 (USP37), which could form a complex with p27 to promote its deubiquitination and stabilization, and resulting in blocked cell proliferation [ xref ]."
reach
"Constitutive expression of USP37 promotes p27 deubiquitination in medulloblastoma cells, whereas a catalytically dead USP37 mutant is unable to stabilize p27.Dobson et al. further explored the molecular basis of REST-induced USP37 downregulation and found that USP37 supresses medulloblastoma tumor growth in an orthotopic mouse model by modulating its downstream targets [87]."
| PMC
"Ectopically expressed wild-type USP37 formed a complex with p27, promoted its deubiquitination and stabilization and blocked cell proliferation."
reach
"Addition of USP37 to a reaction mix containing HA-ubiquitin and Myc-p27 caused a substantial increase in the 27kD form of p27 and a corresponding decrease in the slower migrating forms of the protein relative to reactions containing USP37 and a protease inhibitor N-ethyl maleimide (NEM) or USP37 C350-S or USP1 (XREF_FIG)."
reach
"Since concomitant loss of REST and USP37 expression attenuated p27 stabilization and differentiation and rescued cell proliferation, our data strongly suggest that repression of USP37 and consequent p27 degradation, are important for REST dependent maintenance of cell proliferation."
MiR-320b affects USP37
|
12
MiR-320b activates USP37.
|
5
reach
"The results revealed that 6IH treatment could decrease the expression of miR-320b yet increase that of USP37 and CDT1, and the overexpression of miR-320b could downregulate the expressions of USP37 and CDT1, while the effect of miR-320b mimic on the expressions of miR-320b, USP37, and CDT1 could be counteracted by overexpressed CDT1 (oe-CDT1)."
MiR-320b inhibits USP37.
|
4
MiR-320b decreases the amount of USP37.
|
3
reach
"The results revealed that 6IH treatment could decrease the expression of miR-320b yet increase that of USP37 and CDT1, and the overexpression of miR-320b could downregulate the expressions of USP37 and CDT1, while the effect of miR-320b mimic on the expressions of miR-320b, USP37, and CDT1 could be counteracted by overexpressed CDT1 (oe-CDT1)."
Snail1 affects USP37
|
12
reach
"Constitutive expression of USP37 promotes p27 deubiquitination in medulloblastoma cells, whereas a catalytically dead USP37 mutant is unable to stabilize p27.Dobson et al. further explored the molecular basis of REST-induced USP37 downregulation and found that USP37 supresses medulloblastoma tumor growth in an orthotopic mouse model by modulating its downstream targets [87]."
| PMC
reach
"In medulloblastomas, REST expression could decrease cyclin dependent kinase (CDK) NIB and p27 (a CDK inhibitor) by repressing ubiquitin specific peptidase 37 (USP37), which could form a complex with p27 to promote its deubiquitination and stabilization, and resulting in blocked cell proliferation [XREF_BIBR]."
sparser
"In the case of K48-linked substrates, binding of the UIMs to the proximal Ub increased catalytic efficiency of USP37 largely through k cat and to a lesser degree through K M . This result was somewhat counter-intuitive since we expected that binding of the UIMs of USP37 to Ub to have a more pronounced effect on K M (a proxy for binding affinity) since others have shown that UIM mutations perturbed the ability to pull down Ub conjugates xref ."
sparser
"In the case of K48-linked substrates, binding of the UIMs to the proximal Ub increased catalytic efficiency of USP37 largely through k cat and to a lesser degree through K M . This result was somewhat counter-intuitive since we expected that binding of the UIMs of USP37 to Ub to have a more pronounced effect on K M (a proxy for binding affinity) since others have shown that UIM mutations perturbed the ability to pull down Ub conjugates xref ."
USP37 affects homologous recombination
|
8
USP37 activates homologous recombination.
|
5
USP37 inhibits homologous recombination.
|
2
USP37 increases the amount of homologous recombination.
|
1
USP37 increases the amount of homologous recombination. 1 / 1
|
1
USP37 affects 14-3-3gamma
|
8
reach
"The inactivation of APC and C-CDH 1 is reinforced through the ubiquitin dependent degradation of CDH1 in S phase by the SKP1-Cullin-F-box (SCF) family ubiquitin ligase, SCF-cyclin F, as well as through deubiquitination of the critical APC and C-CDH 1 target cyclin A2 in late G1 and S phases by the E2F induced deubiquitinase USP37."
USP37 affects cell migration
|
7
USP37 activates cell migration.
|
5
USP37 inhibits cell migration.
|
2
USP37 activates USP37.
|
3
reach
"Ambiguously, the transcription of USP37 is suppressed in medulloblastoma cells through the activity of RE1 silencing transcription factor to prevent the USP37 mediated stabilization of the cyclin dependent kinase inhibitor p27, which is known to act as a negative regulator of cell cycle XREF_BIBR."
USP37 phosphorylates USP37.
|
1
USP37 inhibits USP37.
|
1
reach
"Ambiguously, the transcription of USP37 is suppressed in medulloblastoma cells through the activity of RE1 silencing transcription factor to prevent the USP37 mediated stabilization of the cyclin dependent kinase inhibitor p27, which is known to act as a negative regulator of cell cycle XREF_BIBR."
USP37 deubiquitinates USP37.
|
1
sparser
"In medulloblastomas, REST expression could decrease cyclin-dependent kinase (CDK)NIB/p27 (a CDK inhibitor) by repressing ubiquitin specific peptidase 37 (USP37), which could form a complex with p27 to promote its deubiquitination and stabilization, and resulting in blocked cell proliferation [ xref ]."
USP37 affects stemness
|
5
USP37 affects cell invasion
|
5
USP37 affects apoptotic process
|
5
USP37 activates apoptotic process.
|
3
USP37 inhibits apoptotic process.
|
2
USP37 affects 14-3-3γ
|
5
1
|
1
USP37 binds.
1
|
USP37 translocates.
|
1
sparser
"A recent study demonstrated that HBx, an oncoprotein of the hepatitis B virus and a regulator of hepatocarcinogenesis, promoted the translocation of USP37 from the nucleoplasm to the cytoplasm and that the degradation of USP37 seemed to be prevented by the E3 ligases, APC/CDH1 and SCF/β-TrCP [ xref ]."
USP37 affects Snail1 protein
|
4
USP37 affects RAP80-BRCA1
|
1
3
E3_Ub_ligase affects USP37
|
3
1
E3_Ub_ligase activates USP37.
|
2
E3_Ub_ligase ubiquitinates USP37.
|
1
E3_Ub_ligase ubiquitinates USP37. 1 / 1
|
1
E3_Ub_ligase binds USP37.
|
1
E3_Ub_ligase binds USP37. 1 / 1
|
1
14-3-3γ affects USP37
|
4
Valproic acid affects USP37
3
|
Sodium arsenate affects USP37
3
|
Sodium arsenate increases the amount of USP37.
2
|
Sodium arsenate decreases the amount of USP37.
1
|
Hsa-miR-19b-3p affects USP37
3
|
USP37 affects migration
|
3
eidos
"Accumulating evidence has demonstrated that USP37 promotes lung cancer cell proliferation , migration , and invasion16 but inhibits lung cancer cell apoptosis in a deubiquitination-dependent manner.19 Therefore , it is possible that IH-mediated miR-320b reduction in lung cancer cells resulted in the upregulation of USP37 , which further promoted cancer cell proliferation , invasion , and survival ."
USP37 affects doxorubicin
|
3
USP37 activates doxorubicin.
|
2
USP37 activates doxorubicin. 2 / 2
|
2
USP37 inhibits doxorubicin.
|
1
USP37 inhibits doxorubicin. 1 / 1
|
1
USP37 affects Neoplasm Metastasis
|
1
2
USP37 activates Neoplasm Metastasis.
|
1
1
USP37 activates Neoplasm Metastasis. 2 / 2
|
1
1
USP37 inhibits Neoplasm Metastasis.
|
1
USP37 inhibits Neoplasm Metastasis. 1 / 1
|
1
USP37 affects Cell Survival
|
3
USP37 activates Cell Survival.
|
2
USP37 bound to HA-14-3-3gamma activates Cell Survival. 1 / 1
|
1
USP37 activates Cell Survival. 1 / 1
|
1
USP37 inhibits Cell Survival.
|
1
USP37 inhibits Cell Survival. 1 / 1
|
1
USP37 affects APC CDH1
|
3
UIM3 affects USP37
|
1
2
UIM3 activates USP37.
|
1
1
reach
"Therefore, the difference in the ability of the UIMs to bind ubiquitin plays a differential role on the kinetic parameters of USP37 depending on the type of ubiquitin chain, shedding light on the mechanism of substrate selection by USP37.When individual UIM mutants were tested, the authors found that UIM2 and UIM3 modulate the ability of USP37 to cleave all ubiquitin chain types, in contrast with that of UIM1."
| PMC
UIM3 decreases the amount of USP37.
|
1
14-3-3gamma affects USP37
|
3
Hsa-miR-30c-5p affects USP37
2
|
Hsa-miR-19a-3p affects USP37
2
|
USP37 affects tumorigenicity
|
2
USP37 affects tumor growth MCF-7 ADR cells
|
2
USP37 affects smoothened signaling pathway
|
1
1
USP37 inhibits smoothened signaling pathway.
|
1
USP37 inhibits smoothened signaling pathway. 1 / 1
|
1
USP37 activates smoothened signaling pathway.
|
1
USP37 activates smoothened signaling pathway. 1 / 1
|
1
USP37 affects purmorphamine
|
2
USP37 affects polyubiquitin chains
|
2
USP37 inhibits polyubiquitin chains.
|
1
reach
"Interestingly, RAP80 's access to polyubiquitin chains assembled by RNF8 and RNF168 is regulated by HR promoting factors such as RNF169, which competes with RAP80 for binding sites on polyubiquitin [XREF_BIBR], and the DUBs USP26 and USP37, which degrade polyubiquitin chains to reduce RAP80 accumulation [XREF_BIBR]."
USP37 activates polyubiquitin chains.
|
1
USP37 affects Medulloblastoma
|
2
USP37 activates Medulloblastoma. 1 / 1
|
1
USP37 activates Medulloblastoma. 1 / 1
|
1
reach
"Constitutive expression of USP37 promotes p27 deubiquitination in medulloblastoma cells, whereas a catalytically dead USP37 mutant is unable to stabilize p27.Dobson et al. further explored the molecular basis of REST-induced USP37 downregulation and found that USP37 supresses medulloblastoma tumor growth in an orthotopic mouse model by modulating its downstream targets [87]."
| PMC
USP37 affects DNA Breaks, Double-Stranded
|
2
USP37 affects Carcinogenesis
|
1
1
USP37 activates Carcinogenesis. 2 / 2
|
1
1
eidos
"207 In addition to Fbw7 , other E3 ligases , such as beta-TrCP1 , CHIP and FBXO32 , can also ubiquitinate c-Myc , mediate its subsequent degradation and inhibit tumorigenesis.208-210 Moreover , the USP37 and USP36 can promote tumorigenesis by stabilizing c-Myc.211 ,212 By mass spectrometry , SUMO ligase protein inhibitor of activated STAT ( PIAS ) and Sentrin-specific protease 7 ( SENP7 ) were also found to control the SUMOylation of c-Myc at K326 and regulate its ubiquitination and degradation ( Fig. 2c ) .213 Ubiquitination regulates p53 p53 , one of the most important tumor suppressors , works in multiple cellular processes , such as cell cycle regulation , DNA repair and apoptosis ."
UIM2 affects USP37
|
1
1
reach
"Therefore, the difference in the ability of the UIMs to bind ubiquitin plays a differential role on the kinetic parameters of USP37 depending on the type of ubiquitin chain, shedding light on the mechanism of substrate selection by USP37.When individual UIM mutants were tested, the authors found that UIM2 and UIM3 modulate the ability of USP37 to cleave all ubiquitin chain types, in contrast with that of UIM1."
| PMC
APC CDH1 affects USP37
|
2
′-UTR affects USP37
|
1
Vincristine affects USP37
1
|
Vinclozolin affects USP37
1
|
Various affects USP37
|
1
Ubiquitin E3 affects USP37
|
1
Tetrachloromethane affects USP37
1
|
Targeting KEN box degron affects USP37
|
1
eidos
"B In the late G2 / M phase , USP37 acts as a substrate of the APC / C complex via phosphorylation by PLK1 and is further ubiquitinated by betaTrCP for the biphasic degradation , resulting in the downregulation of USP37 , necessary for the G2 / M phase transition Interestingly , the APC-CDH1 complex degrades USP37 in late mitosis by targeting its KEN box degron ."
| PMC
SiRNA#2 and siRNA#3.The affects USP37
|
1
reach
"These results confirmed that USP37 gene expression could be effectively downregulated by siRNA#2 and siRNA#3.The expression of USP37 gene has been demonstrated to be elevated in patients with a recurrence of cancer, indicating that USP37 levels may be closely related to breast cancer distant metastasis [16]."
Polyubiquitin affects USP37
|
1
USP37 binds polyubiquitin. 1 / 1
|
1
Mono(2-ethylhexyl) phthalate affects USP37
1
|
MiR-4487 affects USP37
|
1
MiR-30b-5p affects USP37
|
1
Methyl methanesulfonate affects USP37
1
|
Mechanisms include affects USP37
|
1
Magnetite nanoparticle affects USP37
1
|
Hsa-miR-891a-5p affects USP37
1
|
Hsa-miR-6833-3p affects USP37
1
|
Hsa-miR-6828-5p affects USP37
1
|
Hsa-miR-6820-3p affects USP37
1
|
Hsa-miR-6809-3p affects USP37
1
|
Hsa-miR-616-3p affects USP37
1
|
Hsa-miR-5580-5p affects USP37
1
|
Hsa-miR-548av-3p affects USP37
1
|
Hsa-miR-5003-3p affects USP37
1
|
Hsa-miR-4775 affects USP37
1
|
Hsa-miR-4768-5p affects USP37
1
|
Hsa-miR-4753-3p affects USP37
1
|
Hsa-miR-455-3p affects USP37
1
|
Hsa-miR-4501 affects USP37
1
|
Hsa-miR-4487 affects USP37
1
|
Hsa-miR-4280 affects USP37
1
|
Hsa-miR-4264 affects USP37
1
|
Hsa-miR-3591-5p affects USP37
1
|
Hsa-miR-32-3p affects USP37
1
|
Hsa-miR-3164 affects USP37
1
|
Hsa-miR-3118 affects USP37
1
|
Hsa-miR-30e-5p affects USP37
1
|
Hsa-miR-30b-5p affects USP37
1
|
Hsa-miR-30a-5p affects USP37
1
|
Hsa-miR-302d-5p affects USP37
1
|
Hsa-miR-302b-5p affects USP37
1
|
Hsa-miR-215-3p affects USP37
1
|
Hsa-miR-1910-5p affects USP37
1
|
Hsa-miR-191-5p affects USP37
1
|
Hsa-miR-185-3p affects USP37
1
|
Hsa-miR-130b-5p affects USP37
1
|
Hexabromocyclododecane affects USP37
1
|
Haloperidol affects USP37
1
|
Ethyl methanesulfonate affects USP37
1
|
Dorsomorphin affects USP37
1
|
Diisobutyl phthalate affects USP37
1
|
Chlordecone affects USP37
1
|
Bleomycin A5 affects USP37
1
|
Aflatoxin B1 affects USP37
1
|
Ub-binding site affects USP37
|
1
USP37 affects γ-H2AX foci
|
1
USP37 affects wild-type Snail1
|
1
USP37 affects ubiquitin E3
|
1
USP37 affects tumorigenicity MCF-7
|
1
USP37 affects tumorigenesis lung cancer
|
1
USP37 affects tumor growth
|
1
USP37 affects tumor MCF-7 ADR cells
|
1
USP37 affects stemness cell invasion EMT breast cancer
|
1
USP37 affects stability Gli-1 protein cells
|
1
USP37 affects spheroids
|
1
USP37 affects spheroid
|
1
USP37 affects signal transduction
|
1
USP37 activates signal transduction. 1 / 1
|
1
USP37 affects sensitivity cisplatin
|
1
USP37 affects response to drug
|
1
USP37 activates response to drug. 1 / 1
|
1
USP37 affects resistance breast cancer cells adriamycin
|
1
USP37 affects proteolysis
|
1
USP37 inhibits proteolysis. 1 / 1
|
1
USP37 affects protein folding
|
1
USP37 activates protein folding. 1 / 1
|
1
USP37 affects protein Smo Gli-1
|
1
USP37 affects proteasomal CDT1
|
1
USP37 affects primary kidney tumorigenesis
|
1
USP37 affects polyubiquitination
|
1
USP37 affects polyubiquitination protein
|
1
USP37 affects polyubiquitin
|
1
USP37 binds polyubiquitin. 1 / 1
|
1
USP37 affects oncogenic fusion protein PLZF RARA stability cell transformation potential
|
1
USP37 affects oncogenic fusion PLZF-RARA
|
1
USP37 affects mesenchymal-epithelial transition MET process breast cancer cell lines
|
1
|
1
USP37 inhibits mesenchymal to epithelial transition. 1 / 1
|
1
USP37 affects mammospheres
|
1
USP37 affects lung cancer cell
|
1
eidos
"Accumulating evidence has demonstrated that USP37 promotes lung cancer cell proliferation , migration , and invasion16 but inhibits lung cancer cell apoptosis in a deubiquitination-dependent manner.19 Therefore , it is possible that IH-mediated miR-320b reduction in lung cancer cells resulted in the upregulation of USP37 , which further promoted cancer cell proliferation , invasion , and survival ."
USP37 affects lung cancer cell apoptosis
|
1
eidos
"Accumulating evidence has demonstrated that USP37 promotes lung cancer cell proliferation , migration , and invasion16 but inhibits lung cancer cell apoptosis in a deubiquitination-dependent manner.19 Therefore , it is possible that IH-mediated miR-320b reduction in lung cancer cells resulted in the upregulation of USP37 , which further promoted cancer cell proliferation , invasion , and survival ."
USP37 affects invasion migration breast cancer cells
|
1
USP37 affects invading capacity MCF-7 MDA-MB-231 cells
|
1
USP37 affects intrinsic apoptosis including Bcl-2
|
1
USP37 affects inhibitory adriamycin MCF-7 MCF-7
|
1
USP37 affects hedgehog Hh pathway components Smo
|
1
USP37 affects growth experimental MB
|
1
USP37 affects function response
|
1
USP37 affects entry
|
1
USP37 affects drug sensitivity cisplatin
|
1
USP37 affects disorder cell cycle
|
1
eidos
"The current finding showed that USP37 downregulation leads to disorder of cell cycle during G1 and G1 / S phases of the cell cycle 22 , which confirmed our data that USP37 knockdown altered the cell cycle by increasing the accumulation of the G0 / G1 phase and reducing the cell population in S phase ."
USP37 affects deubiquitination-dependent manner.19
|
1
eidos
"Accumulating evidence has demonstrated that USP37 promotes lung cancer cell proliferation , migration , and invasion16 but inhibits lung cancer cell apoptosis in a deubiquitination-dependent manner.19 Therefore , it is possible that IH-mediated miR-320b reduction in lung cancer cells resulted in the upregulation of USP37 , which further promoted cancer cell proliferation , invasion , and survival ."
USP37 affects deubiquitination HIF2alpha kidney cancer
|
1
USP37 affects deubiquitination CDT1
|
1
USP37 affects complex assembly
|
1
USP37 inhibits complex assembly. 1 / 1
|
1
USP37 affects chromosome segregation
|
1
USP37 activates chromosome segregation. 1 / 1
|
1
USP37 affects chromosomal segregation
|
1
USP37 affects chemoresistance breast cancer cells
|
1
USP37 affects chemical resistance MCF-7 MCF-7
|
1
USP37 affects cellular
|
1
USP37 affects cellular breast cancer cells
|
1
USP37 affects cell migration invasion breast cancer cells
|
1
USP37 affects cell migration capacity
|
1
USP37 affects cell growth
|
1
USP37 inhibits cell growth. 1 / 1
|
1
USP37 affects cell differentiation
|
1
USP37 activates cell differentiation. 1 / 1
|
1
reach
"Since concomitant loss of REST and USP37 expression attenuated p27 stabilization and differentiation and rescued cell proliferation, our data strongly suggest that repression of USP37 and consequent p27 degradation, are important for REST dependent maintenance of cell proliferation."
USP37 affects cancer stem markers
|
1
USP37 affects c-Myc recycling lung cancer
|
1
USP37 affects breast cancer stem-like properties
|
1
USP37 affects bioriented kinetochore-microtubule attachment
|
1
USP37 affects apoptosis investigate latent USP37 transformation breast cancer cells
|
1
USP37 affects adriamycin resistance breast cancer cells
|
1
USP37 affects activation Hh pathway
|
1
USP37 affects Ub-binding site
|
1
USP37 affects Snail1 N-cadherin Vimentin
|
1
USP37 affects S phases cell cycle
|
1
eidos
"The current finding showed that USP37 downregulation leads to disorder of cell cycle during G1 and G1 / S phases of the cell cycle 22 , which confirmed our data that USP37 knockdown altered the cell cycle by increasing the accumulation of the G0 / G1 phase and reducing the cell population in S phase ."
USP37 affects RNF8/168
|
1
USP37 affects PM EMT markers
|
1
USP37 affects MCF-7 ADR cancer cells
|
1
USP37 affects LC3B
|
1
USP37 affects K11
|
1
USP37 affects Hh targets Smo Gli-1 cell marker Ki-67 tumor tissues
|
1
USP37 affects Hemagglutinins
|
1
USP37 affects HIF2alpha protein stability
|
1
USP37 affects HIF2alpha ccRCC
|
1
USP37 affects HA-14-3-3gamma
|
1
USP37 affects G1
|
1
USP37 affects E3_Ub_ligase
|
1
E3_Ub_ligase binds USP37. 1 / 1
|
1
USP37 affects Drug Resistance
|
1
USP37 activates Drug Resistance. 1 / 1
|
1
USP37 affects Deubiquitinase
|
1
USP37 activates Deubiquitinase. 1 / 1
|
1
USP37 affects DSB repair
|
1
USP37 affects DNA replication
|
1
USP37 inhibits DNA replication. 1 / 1
|
1
|
1
USP37 affects Chemical Sensitivity Human Breast Cancer Cells
|
1
USP37 affects CDT1 protein
|
1
USP37 affects CDT1 deubiquitination miR-320b IH-mediated lung cancer
|
1
eidos
"USP37 promotes the expression of CDT1 by deubiquitination miR-320b impaired IH-mediated lung cancer progression by inhibiting CDT1 expression through targeting USP37 To understand whether the regulation of CDT1 expression by USP37 plays a role in lung cancer cell growth and invasion , the expressions of miR-320b and / or CDT1 in lung cancer cells ( A549 and H1650 ) were altered ."
USP37 affects C-Cdh1
|
1
USP37 affects Breast Neoplasms
|
1
USP37 activates Breast Neoplasms. 1 / 1
|
1
USP37 affects BRCA1-A
|
1
USP37 affects BC
|
1
USP37 affects APC/C Cdh1
|
1
USP37 affects ADR cells
|
1
eidos
"Knockdown of USP37 reduces the chemoresistance of MCF-7 and MCF-7 / ADR cells against adriamycin and activates the mechanism of apoptosis USP37 gene expression in both MCF-7 and MCF-7 / ADR cells was markedly upregulated by the exposure to adriamycin in a dose-dependent manner ( Figure 5A-D ) ."
USP37 affects ADR cells adriamycin
|
1
USP37 affects 14-3-3gamma protein
|
1
USP37 affects 5-bromo-2'-deoxyuridine
|
1
USP37 activates 5-bromo-2'-deoxyuridine. 1 / 1
|
1
RNA, Small Interfering affects USP37
|
1
RNA, Small Interfering inhibits USP37. 1 / 1
|
1
REST protein neural cells affects USP37
|
1
Plant Extracts affects USP37
1
|
Overexpression miR-320b affects USP37
|
1
MYC affects Hemagglutinins
|
1
MS-275 affects USP37
|
1
K11 affects USP37
|
1
Hemagglutinins affects USP37
|
1
HA-14-3-3gamma affects USP37
|
1
G9a pharmacological affects USP37
|
1
G1 affects USP37
|
1
reach
"Taken together, our results show that the prolonged treatment of NSCLC cells with gefitinib mediates strong degradation of EGFR, elevating intracellular ubiquitination and autophagy and resulting in apoptotic cell death.In summary, the present study demonstrates that gefitinib-mediated EGFR degradation is dependent on the mutation variations in the EGFR kinase domain, and miR-4487 contributes to the subsequent elevation of gefitinib-mediated ubiquitination, autophagy, and apoptotic cell death by directly targeting USP37."
|
1
EC 3.5.1.98 (histone deacetylase) inhibitor decreases the amount of USP37. 1 / 1
|
1
D-aspartic acid affects USP37
|
1
D-aspartic acid increases the amount of USP37. 1 / 1
|
1
Carcinogenesis affects USP37
|
1
Carcinogenesis activates USP37. 1 / 1
|
1
CDK2 inhibitor affects USP37
|
1
C-Cdh1 affects USP37
|
1
Antigen-Presenting Cells affects USP37
|
1
Antigen-Presenting Cells ubiquitinates USP37. 1 / 1
|
1
APC/C Cdh1 affects USP37
|
1
APC-CDH1 complex affects USP37
|
1
eidos
"B In the late G2 / M phase , USP37 acts as a substrate of the APC / C complex via phosphorylation by PLK1 and is further ubiquitinated by betaTrCP for the biphasic degradation , resulting in the downregulation of USP37 , necessary for the G2 / M phase transition Interestingly , the APC-CDH1 complex degrades USP37 in late mitosis by targeting its KEN box degron ."
| PMC
4-hydroxynon-2-enal affects USP37
1
|
17alpha-ethynylestradiol affects USP37
1
|
14-3-3γ affects MYC
|
1
2,3',4,4',5-pentachlorobiphenyl affects USP37
1
|